Unfortunately with Brandy it has nothing to do with a needle prick. Brandy is severely allergic to desferal. I have always wanted to help her because she has had so much trouble with chelation. For awhile she was on a program that required her to travel to Canada to participate in a special program where she got L1, but the program was changed so only Canadian citizens could take part, so she was again without chelation. Once Exjade became available, she has had another chelator but her ferritin has been very high and it really takes complete compliance and a higher dose of exjade to deal with serious iron overload. She knows she's going to have to get more serious about compliance now, and I have asked her to keep in touch so we can know how she's doing.
Brandy's case is one that has outraged me, because before Exjade was introduced, patients were given no choice when they were allergic to desferal. When Dr Olivieri pulled the plug on research of L1 it left patients with no choice but to die if they couldn't tolerate desferal. She has yet to admit that her research was faulty, nor has she acknowledged the harm done to patients because of her abrupt cessation of the L1 study and her ongoing battle against Apotex. While the press championed Olivieri as a martyr, patients were dying from iron overload and no one cast a thought to their sad lot. My views on this were expressed in a response to a review of the book, The Drug Trial: Nancy Olivieri and the Science Scandal that Rocked the Hospital for Sick Children, by Dr Miriam Schuchman, and can be seen, along with Shilpa's response at
http://bmj.bmjjournals.com/cgi/eletters/331/7508/115Brandy and Lisa were the two people I knew who were most affected by the decision to keep L1 out of the hands of patients who could not tolerate desferal (Brandy's allergy to it being quite severe) and this has been a prime motivation of mine for years. I hope Brandy can beat her iron overload and now that Exjade is available she does have a chance. I really do wish L1 was readily available to patients in North America, as nothing works as well to reduce the iron in an iron overloaded heart.